Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...

Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

Mahindra Lifespace Developers Ltd., Bank of India, Rail Vikas Nigam Ltd., Container Corp. and Cipla Ltd. are some of the ...

The Nifty futures ended on a positive note, gaining 0.21% to close at 23,043 levels on Monday. Meanwhile, the India VIX ...

>> Long build up is seen in CIPLA Futures, where we have seen 4 per cent rise in the open interest on the day when Cipla ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.